Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge

Approximately 20% of stage 4 high-risk neuroblastoma patients are alive and disease-free 5 years after disease onset while the remaining experience rapid and fatal progression. Numerous findings underline the prognostic role of methylation of defined target genes in neuroblastoma without taking into...

Descripción completa

Detalles Bibliográficos
Autores principales: Banelli, Barbara, Merlo, Domenico Franco, Allemanni, Giorgio, Forlani, Alessandra, Romani, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661569/
https://www.ncbi.nlm.nih.gov/pubmed/23717404
http://dx.doi.org/10.1371/journal.pone.0063253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661569/
https://www.ncbi.nlm.nih.gov/pubmed/23717404
http://dx.doi.org/10.1371/journal.pone.0063253

Ejemplares similares